Methods for predicting pregnancy outcome in a subject by hCG assay
The present invention provides a method of predicting pregnancy outcome in a subject by determining the amount of an early pregnancy associated molecular isoform of hCG in a sample. The present invention further provides a method for determining the amount of early pregnancy associated molecular isoforms of human chorionic gonadotropin (hCG) in a sample. The present invention also provides a diagnostic kit for determining the amount of early pregnancy associated hCG in a sample. The present invention additionally provides an antibody which specifically binds to an early pregnancy associated molecular isoform of human chorionic gonadotropin. Finally, the present invention provides methods for detecting trophoblast or non-trophoblast malignancy in a sample.
1. A diagnostic kit for determining amount of an early pregnancy associated molecular isoform of human chorionic gonadotropin (EPMI-hCG) in a sample comprising
(a) a capturing antibody which specifically or preferentially binds to EPMI-hCG recognized by the antibody produced by the hybridoma deposited with the American Type Culture Collection under Designation No. HB-12467; and
(b) reagents permitting the formation of a complex between the capturing antibody and EPMI-hCG in the sample, wherein the capturing antibody is B152.
2. The diagnostic kit of claim 1 , further comprising a detection antibody.
3. The diagnostic kit of claim 2 , wherein the detection antibody is B207.
4. The diagnostic kit of claim 1 , further comprising a control sample containing an amount of EPMI-hCG present in a sample of a normal pregnant subject.
5. The diagnostic kit of claim 1 , further comprising a third antibody which binds to intact non-nicked hCG.
6. The diagnostic kit of claim 5 , wherein the third antibody is B109 produced by the hybridoma deposited with the American Type Culture Collection under Designation No. PTA-1624.
7. The diagnostic kit of claim 5 , further comprising a fourth antibody which binds to intact non-nicked hCG simultaneously with the third antibody.
8. The diagnostic kit of claim 7 , wherein the fourth antibody is B108 produced by the hybridoma deposited with the American Type Culture Collection under Designation No. PTA-1625.